Abstract:Emery Haley, Natalie Luke Department of Clinical Research, Pathnostics, Irvine, CA, USA Correspondence: Natalie Luke, Pathnostics, 15545 Sand Canyon Suite 100, Irvine, CA, 92618, USA, Tel +1-714-966-1221, Fax +1-714-966-1231, Email This article aims to bring clinicians' awareness to the widespread impact of urinary tract infection (UTI) on the lives of women and to the advances that offer hope for future improvements in the diagnosis and management of UTI. Thanks to physiological, anatomical, and lifestyle factor differences, women face heightened vulnerability to UTIs compared to men. In fact, women are four times more likely than men to develop a UTI and around half of these women encounter UTI recurrence, which is a significant source of both physical and psychosocial burdens. Despite the current shortcomings in diagnosis and management, emerging diagnostic technologies promise to identify UTIs more accurately and rapidly, offering women hope for a revolution in UTI management. Meanwhile, clinicians have the opportunity to reduce the psychosocial burden by recognizing the value of patients' lived experiences and ensuring their care plan is in alignment with their patients' goals and expectations for medical care. Keywords: women's health, urinary tract infection, urine culture, multiplex-polymerase chain reaction, metagenomic next-generation sequencing, mass spectrometry UTIs occur anywhere from the urethra to the kidneys, manifesting as cystitis or pyelonephritis based on the infection's location. 1 The symptoms vary between individuals, but commonly cause physical discomfort and pose substantial psychosocial challenges, impacting women's daily lives. UTIs can be conceptualized as falling into a diagnostic spectrum, with varying clinical signs and symptoms. 2 Signs and symptoms of UTI may overlap with other urologic diagnoses, such as incontinence, overactive bladder (OAB), or interstitial cystitis (IC), a.k.a. bladder pain syndrome (BPS). 3,4 Furthermore, distinguishing UTI symptoms can be a significant challenge, especially in long-term care facilities, where residents experience high rates of both asymptomatic bacteriuria (ASB) (up to 80%) 5,6 and cognitive impairment. 7 For example, individuals with Alzheimer's disease, dementia, or other forms of cognitive impairments may be unable to clearly communicate their symptoms. In addition, many older individuals do not experience typical UTI symptoms, including urinary frequency, urinary urgency, and dysuria. In fact, atypical symptoms of UTI, which include nonspecific declines in cognitive or physical function, are frequently the only symptoms in elderly individuals. 8–10 Young children and individuals with disabilities, such as paralysis, are also likely to face diagnostic challenges due to difficulties in recognizing UTI symptoms. Therefore, advanced methods to distinguish infection and inflammation from healthy eubiosis are desperately needed to avoid unnecessary and potentially detrimental treatment resulting from confusing ASB with UTI in these vulnerable populations. The diagnosis of a clinical UTI requires both the presence of symptoms and the confirmation of uropathogenic microorganisms in the urine. The term ASB has been used to describe the presence of bacteria in the urinary tract in the absence of any clinical urinary symptoms. 5 The prevalence of ASB in non-catheterized individuals has been reported to range from < 1–50% depending on sex and age. 11 Historically, because healthy urine was presumed to be sterile, ASB was thought to require treatment. 5 However, evidence that antibiotic treatment of ASB fails to produce a clinical benefit suggests that the presence of bacteriuria in the absence of symptoms should not be treated. 11–13 One exception relevant to women is during pregnancy, when treatment of ASB may be recommended to reduce risks of maternal pyelonephritis, pre-term labor, and/or low birth weight. 14 Limitations in standard urine culture (SUC) have upheld the misconception that urine is sterile. SUC methodology is biased toward detecting classical gram-negative uropathogens, such as Escherichia coli ( E. coli ). Culture-independent, molecular-based methods have now revealed that SUC fails to reproducibly detect the majority of the urobiome. 15–18 Advances in the analysis of microbial communities over the last decade have demonstrated that the urinary tract, particularly the bladder, is home to a resident microbiota, referred to as the urobiome. 13,19–22 The use of next-generation sequencing has revealed that the urobiome, while distinct, exhibits similarities to the microbiomes of the genital skin and/or vaginal mucosa. 23–25 The urobiome has also been shown to chang -Abstract Truncated-

Telehealth and Diagnostic Criteria for UTI: Synthesis of Current Evidence

Real-world evidence: Telemedicine for complicated cases of urinary tract infection

The Diagnosis of Urinary Tract Infections Using a Novel At-home Testing Protocol to Enhance Telemedicine: A Retrospective Analysis

A guide for urogynecologic patient care utilizing telemedicine during the COVID-19 pandemic: review of existing evidence

Factors Contributing to Telemedicine Efficacy in Pediatric Urology

Diagnosis, Treatment, and Prevention of Urinary Tract Infections in Post-Acute and Long-Term Care Settings: A Consensus Statement From AMDA's Infection Advisory Subcommittee

Challenges and proposed improvements for reviewing symptoms and catheter use to identify National Healthcare Safety Network catheter-associated urinary tract infections

A mixed-methods analysis of provider-documented and patient-reported urinary tract infection symptoms among veterans with neurogenic bladder

A global perspective on improving patient care in uncomplicated urinary tract infection: expert consensus and practical guidance

Urinary Tract Infections: Core Curriculum 2024

Abstract 6473: Evaluation of bladder cancer patients' utilization of urologic telehealth services

The Current and Future Use of Telemedicine in Infectious Diseases Practice

Telehealth in long-term care facilities during the Covid-19 pandemic - Lessons learned from patients, physicians, nurses and healthcare workers

1696. the Black Box of Using Health Claims-Based Analyses to Estimate UTI Prevalence in Community-Dwelling Women

The impact of COVID-19 on urology office visits and adoption of telemedicine services

Evaluation of evidence-based practice of catheter associated urinary tract infections prevention in a critical care setting: An integrative review

From Awareness to Action: Pioneering Solutions for Women's UTI Challenges in the Era of Precision Medicine

Patient clinical documentation in telehealth environment: are we collecting appropriate and sufficient information for best practice?

Telehealth Use in Geriatrics Care during the COVID-19 Pandemic-A Scoping Review and Evidence Synthesis

The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future

Concordance between Infectious Disease Society of America Criteria for Urinary Tract Infection Testing and Treating Vs. Emergency Department Actual Practice